Home > Insider Trading > Dexcom Inc

Dexcom Inc (DXCM)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

DexCom (DXCM) Extends Losses on Day 5 Amid Leadership Change

DexCom fell for a fifth straight day on Monday, shedding 3.82 percent to close at $76.25 apiece as investors turned cautious following the announcement of a leadership change after the company’s strong...

Keep Reading →

August 5th, 2025 - News

DexCom, Inc. (NASDAQ:DXCM) Q2 2025 Earnings Call Transcript

Operator: Ladies and gentlemen, welcome to the DexCom Second Quarter 2025 Earnings Release Conference Call. My name is Abby, and I'll be your conference operator today.

Keep Reading →

August 1st, 2025 - News Transcripts

Mizuho Lifts PT on DexCom (DXCM) to $100 From $95, Keeps an Outperform Rating

DexCom, Inc. (NASDAQ:DXCM) is one of the best strong buy healthcare stocks to buy now. On July 16, Mizuho analyst Anthony Petrone raised the firm’s price target on DexCom, Inc.

Keep Reading →

July 25th, 2025 - News

10 Best Strong Buy Healthcare Stocks to Buy Now

On July 21, Jared Holz, Mizuho health care sector strategist, appeared on CNBC's 'The Exchange' to talk about whether any opportunity plays exist within the healthcare sector, and what pains the sector...

Keep Reading →

July 25th, 2025 - Hedge Funds News

Oppenheimer Reaffirms DexCom Buy Rating Amid HHS Wearables Push

DexCom, Inc. (NASDAQ:DXCM) ranks among the best fundamental stocks to buy according to hedge funds. Oppenheimer reaffirmed its $95 price target and Outperform rating for DexCom, Inc.

Keep Reading →

June 29th, 2025 - News

15 Best Fundamental Stocks to Buy According to Hedge Funds

On June 27, U.S.

Keep Reading →

June 28th, 2025 - Hedge Funds News

Goldman Sachs Initiates Coverage of DexCom (DXCM) With Buy Rating

DexCom, a global leader in glucose biosensing systems, stands out for its innovative continuous glucose monitoring (CGM) technology.

Keep Reading →

May 30th, 2025 - News

Billionaire Ken Griffin's 10 Midcap Stock Picks with Huge Upside Potential

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry.

Keep Reading →

May 13th, 2025 - News Stock Analysis

DexCom, Inc. (DXCM): A Bull Case Theory

We came across a bullish thesis on DexCom, Inc. (DXCM) on Substack by Na’s Substack. In this article, we will summarize the bulls’ thesis on DXCM. DexCom, Inc.

Keep Reading →

May 7th, 2025 - News Stock Analysis